Shares of Fredun Pharmaceuticals, one of the leading formulations Company in India, soared over 7.5% today after the company announced a USD 3.2 million (Rs 220 million) order for the sales of cardiac and anti-infectives to East African countries. The order will be executed over a period of 16 months.

Commenting on the order, Fredun Medhora, Managing Director, Fredun Group said, "We are pleased to share this milestone development, which is one of the largest single orders for the Company. This order strengthens our position in the East African region, thereby reinforcing our commitment to improving the lives of people."

Shares of Fredun Pharmaceuticals  are trading at Rs 497, up Rs 34.90, or 7.55%  at the Bombay Stock Exchange (BSE) on Wednesday at 11:09 a.m.

The scrip has touched an intra-day high of Rs 509.70 and low of Rs 473. The total volume of shares traded at the BSE is 24,747.

Currently, the stock is trading down  16.25% from its 52-week high of Rs 597  and above 108.12% over the 52-week low of Rs 215.